$LCID
Lucid Group, Inc. Stock $lcid

$lcid Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000162828022004253 Filed on February 28, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$26.39M	$27.11M	$0.00
YoY Change		581.87%
Cost Of Revenue	$151.5M	$154.9M	$2.500M
YoY Change	5958.92%	4945.5%
Gross Profit	-$125.1M	-$127.8M	$1.100M
YoY Change	-11471.0%	-14204.42%
Gross Profit Margin	-473.94%	-471.34%
Selling, General & Admin	$197.0M	$652.5M	$31.30M
YoY Change	529.38%	632.93%
% of Gross Profit			2845.45%
Research & Development	$163.6M	$750.2M	$169.5M
YoY Change	-3.48%	46.78%
% of Gross Profit			15409.09%
Depreciation & Amortization	$36.29M	$62.91M	$4.770M
YoY Change	660.71%	516.74%
% of Gross Profit			433.64%
Operating Expenses	$360.6M	$1.403B	$2.643M
YoY Change	13543.7%	133.72%
Operating Profit	-$485.7M	-$1.530B	-$1.543M
YoY Change	31376.6%	155.4%
Interest Expense	-$1.263M	$1.374M	-$58.41M
YoY Change	-97.84%	2046.88%
% of Operating Profit
Other Income/Expense, Net	-$558.7M	-$1.049B	-$2.168M
YoY Change	25676.46%	771.91%
Pretax Income	-$1.046B	-$2.580B	-$63.22M
YoY Change	1553.98%	258.51%
Income Tax	$18.00K	$49.00K	$90.45K
% Of Pretax Income
Net Earnings	-$1.046B	-$2.580B	-$63.31M
YoY Change	1551.65%	258.61%
Net Earnings / Revenue	-3962.11%	-9515.55%
Basic Earnings Per Share		-$6.41
Diluted Earnings Per Share	-$646.0K	-$6.41	-$280.9K
COMMON SHARES
Basic Shares Outstanding	1.646B shares	740.4M shares
Diluted Shares Outstanding		740.4M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.263B	$6.263B	$3.593M
YoY Change	174215.31%	918.5%
Cash & Equivalents	$6.263B	$6.263B	$614.4M
Short-Term Investments	$0.00	$0.00
Other Short-Term Assets	$43.33M	$113.7M	$24.50M
YoY Change	76.88%	145.33%	19.04%
Inventory	$127.3M	$127.3M	$1.043M
Prepaid Expenses	$70.35M		$21.84M
Receivables	$3.148M	$3.148M	$260.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.507B	$6.507B	$662.6M
YoY Change	882.1%	882.1%	56.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.344B	$1.344B	$713.3M
YoY Change	88.44%	88.44%	399.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$2.070B
YoY Change
Other Assets	$30.61M	$30.61M	$26.85M
YoY Change	14.0%	14.0%	1164.17%
Total Long-Term Assets	$1.375B	$1.375B	$740.1M
YoY Change	85.74%	85.74%	373.33%
TOTAL ASSETS
Total Short-Term Assets	$6.507B	$6.507B	$662.6M
Total Long-Term Assets	$1.375B	$1.375B	$740.1M
Total Assets	$7.882B	$7.882B	$1.403B
YoY Change	461.9%	461.9%	142.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$41.34M	$41.34M	$17.33M
YoY Change	138.52%	138.52%	36.95%
Accrued Expenses	$43.42M	$43.42M
YoY Change		-73.24%
Deferred Revenue
YoY Change
Short-Term Debt	$15.28M	$15.28M	$980.0K
YoY Change	1459.29%	1459.29%
Long-Term Debt Due	$4.183M	$4.183M
YoY Change
Total Short-Term Liabilities	$396.1M	$396.1M	$185.3M
YoY Change	113.78%	113.78%	181.34%
LONG-TERM LIABILITIES
Long-Term Debt	$1.987B	$1.993B	$0.00
YoY Change		99743.39%
Other Long-Term Liabilities	$188.6M	$1.583B	$39.14M
YoY Change	381.81%	3848.29%	40.82%
Total Long-Term Liabilities	$2.175B	$3.576B	$39.14M
YoY Change	5458.05%	8394.87%	40.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$396.1M	$396.1M	$185.3M
Total Long-Term Liabilities	$2.175B	$3.576B	$39.14M
Total Liabilities	$3.972B	$3.972B	$227.4M
YoY Change	1647.0%	1647.0%	79.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.066B		-$1.357B
YoY Change	347.04%		112.84%
Common Stock	$165.0K		$3.000K
YoY Change	5400.0%		50.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$20.72M		$0.00
YoY Change
Treasury Stock Shares	857.8K shares		0.000 shares
Shareholders Equity	$3.909B	$3.909B	-$1.319B
YoY Change
Total Liabilities & Shareholders Equity	$7.882B	$7.882B	$1.403B
YoY Change	461.9%	461.9%	142.01%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$1.046B	-$2.580B	-$63.31M
YoY Change	1551.65%	258.61%
Depreciation, Depletion And Amortization	$36.29M	$62.91M	$4.770M
YoY Change	660.71%	516.74%
Cash From Operating Activities	-$312.7M	-$1.058B	-$1.076M
YoY Change	28977.01%	85.57%
INVESTING ACTIVITIES
Capital Expenditures	-$121.9M	-$421.2M	$103.7M
YoY Change	-217.53%	-8.35%
Acquisitions
YoY Change
Other Investing Activities	$508.0K	$527.0K	$450.0K
YoY Change	12.89%
Cash From Investing Activities	-$121.4M	-$420.7M	$450.0K
YoY Change	-27077.56%	-8.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$20.72M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.900B	$7.136B	0.000
YoY Change		452.98%
NET CHANGE
Cash From Operating Activities	-312.7M	-$1.058B	-1.076M
Cash From Investing Activities	-121.4M	-$420.7M	450.0K
Cash From Financing Activities	1.900B	$7.136B	0.000
Net Change In Cash	1.465B	$5.658B	-625.5K
YoY Change	-234373.98%	2069.6%
FREE CASH FLOW
Cash From Operating Activities	-$312.7M	-$1.058B	-$1.076M
Capital Expenditures	-$121.9M	-$421.2M	$103.7M
Free Cash Flow	-$190.8M	-$636.9M	-$104.8M
YoY Change	82.09%	475.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001811210
CY2020	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201602Member
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-39408
CY2021	dei	Entity Registrant Name EntityRegistrantName	Lucid Group, Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-0891392
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	7373 Gateway Boulevard
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Newark
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94560
CY2021	dei	City Area Code CityAreaCode	510
CY2021	dei	Local Phone Number LocalPhoneNumber	648-3553
CY2021	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.0001 par value per share
CY2021	dei	Trading Symbol TradingSymbol	LCID
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	5500000000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1653257009	shares
CY2021	dei	Auditor Firm AuditorFirmId	248
CY2021	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2021	dei	Auditor Location AuditorLocation	San Francisco, California
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6262905000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	614412000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3148000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	260000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	505000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	127250000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1043000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	70346000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	21840000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	43328000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	24496000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	6506977000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	662556000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1182153000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	713274000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	161974000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	30609000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	26851000	USD
CY2021Q4	us-gaap	Assets Assets	7881713000	USD
CY2020Q4	us-gaap	Assets Assets	1402681000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	41342000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	17333000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	32364000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	16197000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4183000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	0	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	318212000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	151753000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	396101000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	185283000	USD
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2960000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6083000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	USD
CY2021Q4	lcid	Common Stock Warrant Liabilities CommonStockWarrantLiabilities	1394808000	USD
CY2020Q4	lcid	Common Stock Warrant Liabilities CommonStockWarrantLiabilities	0	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1986791000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	188575000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	39139000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	3972358000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	227382000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	0	shares
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1058949780	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	957159704	shares
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	957159704	shares
CY2021Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	0	USD
CY2020Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	3497913000	USD
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	2494076000	USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1189800259	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1648413415	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28791702	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1647555590	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28791702	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	165000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	3000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9995778000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	38113000	USD
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	857825	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	20716000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6065872000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1356893000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3909355000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1318777000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7881713000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1402681000	USD
CY2021	us-gaap	Revenues Revenues	27111000	USD
CY2020	us-gaap	Revenues Revenues	3976000	USD
CY2019	us-gaap	Revenues Revenues	4590000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	154897000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	3070000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	3926000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	750185000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	511110000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	220223000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	652475000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	89023000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	38375000	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	1557557000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	603203000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	262524000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-1530446000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-599227000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-257934000	USD
CY2021	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	454546000	USD
CY2020	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	118382000	USD
CY2019	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Issuers Equity FairValueAdjustmentOfForwardContractsIndexedToIssuersEquity	15053000	USD
CY2021	lcid	Reverse Recapitalization Transaction Costs Expensed ReverseRecapitalizationTransactionCostsExpensed	2717000	USD
CY2020	lcid	Reverse Recapitalization Transaction Costs Expensed ReverseRecapitalizationTransactionCostsExpensed	0	USD
CY2019	lcid	Reverse Recapitalization Transaction Costs Expensed ReverseRecapitalizationTransactionCostsExpensed	0	USD
CY2021	us-gaap	Interest Expense InterestExpense	1374000	USD
CY2020	us-gaap	Interest Expense InterestExpense	64000	USD
CY2019	us-gaap	Interest Expense InterestExpense	8547000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-893000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-690000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4606000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1049266000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-120341000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-19400000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2579712000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-719568000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-277334000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	49000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-188000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2579761000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2579761000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-719380000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-719380000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-277357000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-277357000	USD
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2167332000	USD
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
CY2019	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4747093000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-705596000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-269422000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	740393759	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	740393759	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24825944	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24825944	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20595229	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20595229	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20595229	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20595229	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.41
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.41
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-28.42
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-28.42
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-13.08
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-13.08
CY2018Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	137248112	shares
CY2018Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	259960000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-359860000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-277357000	USD
CY2019	lcid	Adjustments To Additional Paid In Capital Repurchase Of Temporary Equity AdjustmentsToAdditionalPaidInCapitalRepurchaseOfTemporaryEquity	-2469000	USD
CY2019	lcid	Adjustments To Additional Paid In Capital Extinguishment Of Temporary AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfTemporary	10404000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	483000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7719000	USD
CY2019Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	502582534	shares
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1074010000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-621080000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-719380000	USD
CY2020	lcid	Adjustments To Additional Paid In Capital Extinguishment Of Temporary AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfTemporary	1000000	USD
CY2020	lcid	Adjustments To Additional Paid In Capital Repurchase Of Temporary Equity AdjustmentsToAdditionalPaidInCapitalRepurchaseOfTemporaryEquity	12784000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3285000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4614000	USD
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	957159704	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	2494076000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1318777000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2579761000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-719380000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2579761000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	2151613000	USD
CY2021	lcid	Reclassifications Of Temporary To Permanent Equity Shares ReclassificationsOfTemporaryToPermanentEquityShares	1155909367	shares
CY2021	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	5836785000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	5836785000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3590956000	USD
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	22063000	USD
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	20716000	USD
CY2021	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	601176	shares
CY2021	lcid	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	173273000	USD
CY2021	lcid	Warrants Redeemed Or Called During Period Value WarrantsRedeemedOrCalledDuringPeriodValue	4000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8132000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	393143000	USD
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3909355000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-277357000	USD
CY2021	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	62907000	USD
CY2020	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	10217000	USD
CY2019	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	3842000	USD
CY2021	lcid	Amortization Of Insurance Premiums AmortizationOfInsurancePremiums	18474000	USD
CY2020	lcid	Amortization Of Insurance Premiums AmortizationOfInsurancePremiums	0	USD
CY2019	lcid	Amortization Of Insurance Premiums AmortizationOfInsurancePremiums	0	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	12563000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	0	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	0	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	516757000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	4614000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	7719000	USD
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-52000	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-139000	USD
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-30000	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	237000	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3394000	USD
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	48884000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2021	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Equity FairValueAdjustmentOfForwardContractsIndexedToEquity	-454546000	USD
CY2020	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Equity FairValueAdjustmentOfForwardContractsIndexedToEquity	-118382000	USD
CY2019	lcid	Fair Value Adjustment Of Forward Contracts Indexed To Equity FairValueAdjustmentOfForwardContractsIndexedToEquity	-15053000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2888000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-148000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-984000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	175091000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	359000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	188000	USD
CY2021	lcid	Increase Decrease In Financed Insurance Premium IncreaseDecreaseInFinancedInsurancePremium	41935000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5843000	USD
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-10019000	USD
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-69861000	USD
CY2020	lcid	Increase Decrease In Financed Insurance Premium IncreaseDecreaseInFinancedInsurancePremium	0	USD
CY2019	lcid	Increase Decrease In Financed Insurance Premium IncreaseDecreaseInFinancedInsurancePremium	0	USD
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	25045000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-7770000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	27590000	USD
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	14704000	USD
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-7360000	USD
CY2019	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	5010000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-5889000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-2866000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-6143000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4354000	USD
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	16167000	USD
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	13249000	USD
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2774000	USD
CY2019	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	USD
CY2021	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	505000	USD
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	65456000	USD
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	53454000	USD
CY2019	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	28658000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-4712000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1058133000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-570196000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-235299000	USD
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	421220000	USD
CY2020	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	459582000	USD
CY2019	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	104290000	USD
CY2020	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	USD
CY2019	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		USD
CY2021	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	22000	USD
CY2020	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	USD
CY2019	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-420693000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-459582000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-104290000	USD
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2002437000	USD
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2019	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	70949000	USD
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	15883000	USD
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	27887000	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2021	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
CY2020	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	364000	USD
CY2019	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3088000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	USD
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	USD
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	41935000	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2019	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8132000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3285000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	483000	USD
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	173273000	USD
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2021	lcid	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	4439153000	USD
CY2020	lcid	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	0	USD
CY2019	lcid	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	0	USD
CY2021	lcid	Payment Of Reverse Recapitalization Transaction Costs PaymentOfReverseRecapitalizationTransactionCosts	38865000	USD
CY2020	lcid	Payment Of Reverse Recapitalization Transaction Costs PaymentOfReverseRecapitalizationTransactionCosts	0	USD
CY2019	lcid	Payment Of Reverse Recapitalization Transaction Costs PaymentOfReverseRecapitalizationTransactionCosts	0	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	20716000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	22063000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7136428000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1290545000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	621432000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5657602000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	260767000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	281843000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	640418000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	379651000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97808000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6298020000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	640418000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	379651000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	627000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	51000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	30000	USD
CY2021	lcid	Change In Capital Expenditures Incurred But Not Yet Paid ChangeInCapitalExpendituresIncurredButNotYetPaid	101057000	USD
CY2020	lcid	Change In Capital Expenditures Incurred But Not Yet Paid ChangeInCapitalExpendituresIncurredButNotYetPaid	117946000	USD
CY2019	lcid	Change In Capital Expenditures Incurred But Not Yet Paid ChangeInCapitalExpendituresIncurredButNotYetPaid	32863000	USD
CY2021	lcid	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	93771000	USD
CY2020	lcid	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	3289000	USD
CY2019	lcid	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	451000	USD
CY2021	lcid	Extinguishment Of Convertible Preferred Stock Included In Additional Paid In Capital ExtinguishmentOfConvertiblePreferredStockIncludedInAdditionalPaidInCapital	0	USD
CY2020	lcid	Extinguishment Of Convertible Preferred Stock Included In Additional Paid In Capital ExtinguishmentOfConvertiblePreferredStockIncludedInAdditionalPaidInCapital	1000000	USD
CY2019	lcid	Extinguishment Of Convertible Preferred Stock Included In Additional Paid In Capital ExtinguishmentOfConvertiblePreferredStockIncludedInAdditionalPaidInCapital	0	USD
CY2021	lcid	Extinguishment Of Convertible Preferred Stock Included In Accrued Liabilities ExtinguishmentOfConvertiblePreferredStockIncludedInAccruedLiabilities	0	USD
CY2020	lcid	Extinguishment Of Convertible Preferred Stock Included In Accrued Liabilities ExtinguishmentOfConvertiblePreferredStockIncludedInAccruedLiabilities	3000000	USD
CY2019	lcid	Extinguishment Of Convertible Preferred Stock Included In Accrued Liabilities ExtinguishmentOfConvertiblePreferredStockIncludedInAccruedLiabilities	0	USD
CY2021	lcid	Issuance Of Convertible Preferred Stock Upon Exercise Of Preferred Stock Warrants IssuanceOfConvertiblePreferredStockUponExerciseOfPreferredStockWarrants	9936000	USD
CY2020	lcid	Issuance Of Convertible Preferred Stock Upon Exercise Of Preferred Stock Warrants IssuanceOfConvertiblePreferredStockUponExerciseOfPreferredStockWarrants	0	USD
CY2019	lcid	Issuance Of Convertible Preferred Stock Upon Exercise Of Preferred Stock Warrants IssuanceOfConvertiblePreferredStockUponExerciseOfPreferredStockWarrants	0	USD
CY2021	lcid	Deferred Financing Cost Reclassed To Convertible Preferred Stock DeferredFinancingCostReclassedToConvertiblePreferredStock	0	USD
CY2020	lcid	Deferred Financing Cost Reclassed To Convertible Preferred Stock DeferredFinancingCostReclassedToConvertiblePreferredStock	0	USD
CY2019	lcid	Deferred Financing Cost Reclassed To Convertible Preferred Stock DeferredFinancingCostReclassedToConvertiblePreferredStock	10253000	USD
CY2021	lcid	Issuance Of Convertible Preferred Share Contingent Forward Contracts IssuanceOfConvertiblePreferredShareContingentForwardContracts	2167332000	USD
CY2020	lcid	Issuance Of Convertible Preferred Share Contingent Forward Contracts IssuanceOfConvertiblePreferredShareContingentForwardContracts	793000	USD
CY2019	lcid	Issuance Of Convertible Preferred Share Contingent Forward Contracts IssuanceOfConvertiblePreferredShareContingentForwardContracts	0	USD
CY2021	lcid	Capital Contribution Upon Issuance Of Preferred Shares CapitalContributionUponIssuanceOfPreferredShares	15719000	USD
CY2020	lcid	Capital Contribution Upon Issuance Of Preferred Shares CapitalContributionUponIssuanceOfPreferredShares	0	USD
CY2019	lcid	Capital Contribution Upon Issuance Of Preferred Shares CapitalContributionUponIssuanceOfPreferredShares	0	USD
CY2021	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	5836785000	USD
CY2020	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
CY2019	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
CY2021	us-gaap	Nature Of Operations NatureOfOperations	DESCRIPTION OF BUSINESS<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lucid Group, Inc. (“Lucid”) is a automotive company focused on designing, developing, manufacturing, and selling the next generation of electric vehicle (“EV”), EV powertrains and battery systems.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lucid was originally incorporated in Delaware on April 30, 2020 under the name Churchill Capital Corp IV (formerly known as Annetta Acquisition Corp) (“Churchill”) as a special purpose acquisition company with the purpose of effecting a merger with one or more operating businesses. On February 22, 2021, Churchill entered into a definitive merger agreement (the “Merger Agreement”) with Atieva, Inc. (“Legacy Lucid”) in which Legacy Lucid would become a wholly owned subsidiary of Churchill (the “Merger”). Upon the closing of the Merger on July 23, 2021 (the “Closing”), Churchill was immediately renamed to “Lucid Group, Inc.” The Merger between Churchill and Legacy Lucid was accounted for as a reverse recapitalization. See Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">– Reverse Recapitalization for more information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the notes to the consolidated financial statements, unless otherwise noted, the “Company,” “we,” “us” or “our” and similar terms refer to Legacy Lucid and its subsidiaries prior to the consummation of the Merger, and Lucid and its subsidiaries after the consummation of the Merger.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company devotes its efforts to business planning, research and development, recruiting of management and technical staff, acquiring operating assets, and raising capital.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception through December 31, 2021, the Company has incurred operating losses and negative cash flows from operating activities. For the years ended December 31, 2021, 2020 and 2019, the Company has incurred operating losses, including net losses of $2.6 billion, $719.4 million and $277.4 million, respectively. The Company has an accumulated deficit of $6.1 billion as of December 31, 2021. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended June 30, 2021, the Company completed the first phase of the construction of its newly built manufacturing plant in Casa Grande, Arizona (the “Arizona plant”). The Company began commercial production of its first vehicle, the Lucid Air, in September 2021 and delivered its first vehicles in late October 2021. The Company continues to expand the Arizona plant and build-out of a network of retail sales and service locations. The Company has plans for continued development of additional vehicle model types for future release. The aforementioned activities will require considerable capital, above and beyond the expected cash inflows from the initial sales of the Lucid Air. As such, the future operating plan involves considerable risk if secure funding sources are not identified and confirmed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s existing sources of liquidity include cash and cash equivalents. Historically, the Company funded operations primarily with issuances of convertible preferred stock and convertible notes. Upon the completion of the Merger, the Company received $4,400.3 million in cash proceeds, net of transaction costs.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2021, the Company issued an aggregate of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2,012.5 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> principal amount of 1.25% convertible senior notes due in December 2026. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Significant Risks and Uncertainties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s current business activities consist of research and development efforts to design and develop a high-performance fully electric vehicle and advanced electric vehicle powertrain components, including battery pack systems; building of the Company’s production operations in Casa Grande, Arizona; and build-out of the Company’s retail stores and service centers for distribution of the vehicles to customers. The Company is subject to the risks associated with such activities, including the need to further develop its technology, its marketing, and distribution channels; further develop its supply chain and manufacturing; and hire additional management and other key personnel. Successful completion of the Company’s development program and, ultimately, the attainment of profitable operations are dependent upon future events, including our ability to access potential markets, and secure long-term financing.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company participates in a dynamic high-technology industry. Changes in any of the following areas could have a material adverse impact on the Company’s future financial position, results of operations, and/or cash flows: advances and trends in new technologies; competitive pressures; changes in the overall demand for its products and services; acceptance of the Company’s products and services; litigation or claims against the Company based on intellectual property, patent, regulatory, or other factors; and the Company’s ability to attract and retain employees necessary to support its growth.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to impact the global economy and cause significant macroeconomic uncertainty. Infection rates vary across the jurisdictions in which we operate. Governmental authorities have continued to implement numerous and constantly evolving </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measures to try to contain the virus, such as travel bans and restrictions, masking recommendations and mandates, vaccine recommendations and mandates, limits on gatherings, quarantines, shelter-in-place orders and business shutdowns. We have taken proactive action to protect the health and safety of our employees, customers, partners and suppliers, consistent with the latest and evolving governmental guidelines. We expect to continue to implement appropriate measures until the COVID-19 pandemic is adequately contained. We continue to monitor the rapidly evolving situation and guidance from international and domestic authorities, including federal, state and local public health authorities, and may take additional actions based on their recommendations and requirements or as we otherwise see fit to protect the health and safety of our employees, customers, partners and suppliers.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While certain of our and our suppliers’ operations have from time-to-time been temporarily affected by government-mandated restrictions, we were able to commence deliveries of the Lucid Air to customers and to proceed with the construction of the Arizona plant. Broader impacts of the pandemic have included ongoing, industry-wide challenges in logistics and supply chains, such as increased port congestion, intermittent supplier delays and a shortfall of semiconductor supply. Because we rely on third party suppliers for the development, manufacture, and/or provision and development of many of the key components and materials used in our vehicles, as well as provisioning and servicing equipment in our manufacturing facilities, we have been affected by such industry-wide challenges in logistics and supply chains. While we continue to focus on mitigating risks to our operations and supply chain in the current industry environment, we expect that these industry-wide trends will continue to affect our ability and the ability of our suppliers to obtain parts, components and manufacturing equipment on a timely basis for the foreseeable future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the current circumstances, given the dynamic nature of the situation, any impact on our financial condition, results of operations or cash flows in the future continues to be difficult to estimate and predict, as it depends on future events that are highly uncertain and cannot be predicted with accuracy, including, but not limited to, the duration and continued spread of the outbreak, its severity, potential additional waves of infection, the emergence of more virulent or more dangerous strains of the virus, the actions taken to mitigate the virus or its impact, the development, distribution, efficacy and acceptance of vaccines worldwide, how quickly and to what extent normal economic and operating conditions can resume, the broader impact that the pandemic is having on the economy and our industry and specific implications the pandemic may have on our suppliers and on global logistics. See Item 1A., “Risk Factors,” for additional information regarding risks associated with the COVID-19 pandemic, including under the caption “The ongoing COVID-19 pandemic has adversely affected our business, results of operations and financial condition.”</span></div>
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2600000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-719400000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-277400000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6100000000	USD
CY2021Q3	lcid	Proceeds From Reverse Recapitalization Net Of Transaction Costs ProceedsFromReverseRecapitalizationNetOfTransactionCosts	4400300000	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Significant estimates, assumptions and judgments made by management include, among others, the determination of the useful lives of property and equipment, fair value of preferred stock warrants, fair value of common stock warrants, fair value of contingent forward contracts liability, valuation of deferred income tax assets and uncertain tax positions, fair value of common stock and other assumptions used to measure stock-based compensation expense, and estimated incremental borrowing rates for assessing operating and financing lease liabilities. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.</span></div>
CY2021Q4	us-gaap	Cash Cash	6262905000	USD
CY2020Q4	us-gaap	Cash Cash	614412000	USD
CY2019Q4	us-gaap	Cash Cash	351684000	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10740000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	11278000	USD
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	19767000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	24375000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	14728000	USD
CY2019Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	8200000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6298020000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	640418000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	379651000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	500000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Credit RiskFinancial instruments that potentially subject the Company to concentration of credit risk consist of cash, cash equivalents, and accounts receivable. The Company places its cash primarily with domestic financial institutions that are federally insured within statutory limits, but at times its deposits may exceed federally insured limits. Further, accounts receivable primarily consists of current trade receivables from a single customer as of December 31, 2021 and 2020, which relates specifically to sales of its battery packs.
CY2021	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, such as property, plant and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for potential impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent the carrying amount of the underlying asset exceeds its fair value. No impairment loss was recognized for the years ended December 31, 2021, 2020 and 2019.</span></div>
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2019	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2021	lcid	Number Of Performance Obligations NumberOfPerformanceObligations	2	installment
CY2021	lcid	Basic Vehicle Warranty Term BasicVehicleWarrantyTerm	P4Y
CY2021	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	WarrantiesThe Company provides a manufacturer’s warranty on all vehicles and battery packs it sells and accrues a warranty reserve for warranty coverage, as applicable. These estimates are based on actual claims incurred to date and an estimate of the nature, frequency, and costs of future claims. The Company accrues a warranty reserve for all products sold which includes the Company’s best estimates of the projected costs to repair or replace items under warranties and recalls when identified. Changes to the Company’s historical or projected warranty experience may cause material changes to the warranty reserve in the future. The portion of the warranty reserve expected to be incurred within the next 12 months is included within accrued liabilities and other, while the remaining balance is included within other long-term liabilities in the consolidated balance sheets. The warranty expense recorded as a component of cost of revenue in the consolidated statements of operations was immaterial for the years ended December 31, 2021, 2020, and 2019.
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	21840000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	713274000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	151753000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	39139000	USD
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	451295965	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	451295965	shares
CY2021Q3	lcid	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	10.00
CY2021Q3	lcid	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	2.644
CY2021Q3	lcid	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments And Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsAndOptionsOutstandingNumber	42182931	shares
CY2021Q3	lcid	Share Based Payment Award Equity Instruments And Options Converted Reverse Recapitalization ShareBasedPaymentAwardEquityInstrumentsAndOptionsConvertedReverseRecapitalization	111531080	shares
CY2021Q3	lcid	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	10.00
CY2021Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	437182072	shares
CY2021Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	437182072	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	451295965	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	451295965	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	25764610	shares
CY2021Q3	lcid	Share Based Payment Award Options Converted ShareBasedPaymentAwardOptionsConverted	68121210	shares
CY2021Q3	us-gaap	Cash Cash	400000	USD
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2500000000	USD
CY2021Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	85750000	shares
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	16418321	shares
CY2021Q3	lcid	Share Based Payment Award Non Option Equity Instruments Converted Reverse Recapitalization ShareBasedPaymentAwardNonOptionEquityInstrumentsConvertedReverseRecapitalization	43409870	shares
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2500000000	USD
CY2021Q3	lcid	Reverse Recapitalization Working Capital Loan Converted Amount ReverseRecapitalizationWorkingCapitalLoanConvertedAmount	1500000	USD
CY2021Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1500000	shares
CY2021Q3	lcid	Debt Conversion Converted Instrument Warrants Or Options Issued Price Per Warrant DebtConversionConvertedInstrumentWarrantsOrOptionsIssuedPricePerWarrant	1.00
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Shares ReverseRecapitalizationContingentConsiderationShares	17250000	shares
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021Q3	lcid	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	10.00
CY2021Q3	lcid	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	425395023	shares
CY2021Q3	lcid	Stock Converted Reverse Recapitalization StockConvertedReverseRecapitalization	1193226511	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1618621534	shares
CY2021Q3	lcid	Share Based Payment Award Equity Instruments And Options Converted Reverse Recapitalization ShareBasedPaymentAwardEquityInstrumentsAndOptionsConvertedReverseRecapitalization	111531080	shares
CY2021Q3	lcid	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	4439200000	USD
CY2021Q3	lcid	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	2070100000	USD
CY2021Q3	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	21644	shares
CY2019	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	3800000	USD
CY2021Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	200000	USD
CY2021Q3	lcid	Reverse Recapitalization Transaction Costs Incurred ReverseRecapitalizationTransactionCostsIncurred	38900000	USD
CY2021Q3	lcid	Adjustments To Additional Paid In Capital Reduction For Reverse Recapitalization Transaction Costs AdjustmentsToAdditionalPaidInCapitalReductionForReverseRecapitalizationTransactionCosts	36200000	USD
CY2021Q3	lcid	Reverse Recapitalization Transaction Costs Expensed ReverseRecapitalizationTransactionCostsExpensed	2700000	USD
CY2021Q3	lcid	Proceeds From Reverse Recapitalization Net Of Transaction Costs ProceedsFromReverseRecapitalizationNetOfTransactionCosts	4400300000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	87646000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	661000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	30641000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	70000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8963000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	312000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	127250000	USD
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	48900000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1043000	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	1268166000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	738045000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	86013000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	24771000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1182153000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	713274000	USD
CY2021	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	62900000	USD
CY2020	lcid	Depreciation And Amortization Excluding Debt Discounts And Insurance Premiums DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums	10200000	USD
CY2021Q4	lcid	Engineering Design And Testing Liability Current EngineeringDesignAndTestingLiabilityCurrent	33950000	USD
CY2020Q4	lcid	Engineering Design And Testing Liability Current EngineeringDesignAndTestingLiabilityCurrent	42518000	USD
CY2020Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Current SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent	3000000	USD
CY2021Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	92590000	USD
CY2020Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	43115000	USD
CY2021Q4	lcid	Tenant Improvement Liability Current TenantImprovementLiabilityCurrent	15796000	USD
CY2020Q4	lcid	Tenant Improvement Liability Current TenantImprovementLiabilityCurrent	6114000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	13944000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	9083000	USD
CY2021Q4	lcid	Tooling Liability Current ToolingLiabilityCurrent	23966000	USD
CY2020Q4	lcid	Tooling Liability Current ToolingLiabilityCurrent	15243000	USD
CY2021Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Current SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent	0	USD
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	15281000	USD
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	980000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11056000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2021Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	111629000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	31700000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	318212000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	151753000	USD
CY2021Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2020Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	28881000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	185323000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2021Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	3252000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	10258000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	188575000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	39139000	USD
CY2021Q2	us-gaap	Share Price SharePrice	23.78
CY2017Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2	shares
CY2017Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1546799	shares
CY2017Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.94
CY2020Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1546799	shares
CY2020Q4	lcid	Class Of Warrant Or Right Fair Value Per Share ClassOfWarrantOrRightFairValuePerShare	1.94
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3000000	USD
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.94
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3000000	USD
CY2021Q1	lcid	Temporary Equity Stock Issued During Period Value Warrant Exercises TemporaryEquityStockIssuedDuringPeriodValueWarrantExercises	12900000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1200000	USD
CY2021Q1	lcid	Probability Weighted Expected Return Method Number Of Scenarios Considered ProbabilityWeightedExpectedReturnMethodNumberOfScenariosConsidered	3	scenario
CY2021Q1	lcid	Probability Weighted Expected Return Method Number Of Scenarios Considered ProbabilityWeightedExpectedReturnMethodNumberOfScenariosConsidered	3	scenario
CY2021Q1	lcid	Probability Weighted Expected Return Method Likelihood Percentage Of Opm Scenario ProbabilityWeightedExpectedReturnMethodLikelihoodPercentageOfOPMScenario	0.20
CY2021Q1	lcid	Probability Weighted Expected Return Method Likelihood Percentage Of As Converted Spac Scenario ProbabilityWeightedExpectedReturnMethodLikelihoodPercentageOfAsConvertedSPACScenario	0.70
CY2021Q1	lcid	Probability Weighted Expected Return Method Likelihood Percentage Of As Converted Ipo Scenario ProbabilityWeightedExpectedReturnMethodLikelihoodPercentageOfAsConvertedIPOScenario	0.10
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021Q4	lcid	Reverse Recapitalization Contingent Consideration Warrants Vested ReverseRecapitalizationContingentConsiderationWarrantsVested	14783333	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	lcid	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	425395023	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1618621534	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2020Q3	lcid	Number Of Milestone Conditions Required To Receive Funding NumberOfMilestoneConditionsRequiredToReceiveFunding	2	condition
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1316758889	shares
CY2021Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1155909398	shares
CY2020Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1058949780	shares
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	957159704	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	2494076000	USD
CY2020Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	3497913000	USD
CY2021Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1	shares
CY2021Q4	lcid	Convertible Stock Percentage Of Holders Required To Trigger Conversion ConvertibleStockPercentageOfHoldersRequiredToTriggerConversion	0.6667
CY2021Q4	lcid	Convertible Stock Pre Offering Market Capitalization Threshold To Trigger Conversion ConvertibleStockPreOfferingMarketCapitalizationThresholdToTriggerConversion	2500000000	USD
CY2021Q4	lcid	Convertible Stock Ipo Gross Proceeds Required To Trigger Conversion ConvertibleStockIPOGrossProceedsRequiredToTriggerConversion	200000000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	lcid	Common Stock Voting Rights Number Of Votes Allowed For Each Share CommonStockVotingRightsNumberOfVotesAllowedForEachShare	1	vote
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021	lcid	Class Of Warrant Or Right Number Of Warrants Exercised ClassOfWarrantOrRightNumberOfWarrantsExercised	41034197	shares
CY2021	lcid	Class Of Warrant Or Right Number Of Warrants Exercised In Noncash Transaction ClassOfWarrantOrRightNumberOfWarrantsExercisedInNoncashTransaction	25966976	shares
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	173300000	USD
CY2021	lcid	Class Of Warrant Or Right Warrants Redeemed Or Called During Period Shares ClassOfWarrantOrRightWarrantsRedeemedOrCalledDuringPeriodShares	365803	shares
CY2021Q4	lcid	Class Of Warrant Or Right Redemption Price ClassOfWarrantOrRightRedemptionPrice	0.01
CY2021Q4	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	857825	shares
CY2021Q4	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	24.15
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	210204258	shares
CY2020Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1039908056	shares
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Contingency Period ReverseRecapitalizationContingentConsiderationContingencyPeriod	P5Y
CY2021Q4	lcid	Reverse Recapitalization Contingent Consideration Shares Vested ReverseRecapitalizationContingentConsiderationSharesVested	17250000	shares
CY2021Q4	lcid	Reverse Recapitalization Contingent Consideration Warrants Vested ReverseRecapitalizationContingentConsiderationWarrantsVested	14783333	shares
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Shares ReverseRecapitalizationContingentConsiderationShares	17250000	shares
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Shares Number Of Tranches ReverseRecapitalizationContingentConsiderationSharesNumberOfTranches	3	tranche
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants ReverseRecapitalizationContingentConsiderationWarrants	14783333	shares
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants Number Of Tranches ReverseRecapitalizationContingentConsiderationWarrantsNumberOfTranches	3	tranche
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Shares Number Of Tranches ReverseRecapitalizationContingentConsiderationSharesNumberOfTranches	3	tranche
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants Number Of Tranches ReverseRecapitalizationContingentConsiderationWarrantsNumberOfTranches	3	tranche
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants Target Share Price Threshold Trading Days ReverseRecapitalizationContingentConsiderationWarrantsTargetSharePriceThresholdTradingDays	40	day
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants Target Share Price Threshold Consecutive Trading Days ReverseRecapitalizationContingentConsiderationWarrantsTargetSharePriceThresholdConsecutiveTradingDays	60	day
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants Target Share Price Threshold Trading Days ReverseRecapitalizationContingentConsiderationWarrantsTargetSharePriceThresholdTradingDays	40	day
CY2021Q3	lcid	Reverse Recapitalization Contingent Consideration Warrants Target Share Price Threshold Consecutive Trading Days ReverseRecapitalizationContingentConsiderationWarrantsTargetSharePriceThresholdConsecutiveTradingDays	60	day
CY2021Q4	lcid	Reverse Recapitalization Contingent Consideration Shares Vested ReverseRecapitalizationContingentConsiderationSharesVested	17250000	shares
CY2021Q4	lcid	Reverse Recapitalization Contingent Consideration Warrants Vested ReverseRecapitalizationContingentConsiderationWarrantsVested	14783333	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	69305845	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.60
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M18D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	21236000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	23820351	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.16
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	7502955	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.43
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	14947923	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.44
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	70675318	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.84
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M18D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	118155000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	8402925	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.85
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	11076026	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.74
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3882315	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.55
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	64119902	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M6D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2370666000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	42924175	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.79
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y7M6D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1599512000	USD
CY2021	lcid	Finance Lease Cost FinanceLeaseCost	3480000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	206700000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8300000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	400000	USD
CY2021	lcid	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue	24000000.0	USD
CY2020	lcid	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue	14800000	USD
CY2019	lcid	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue	13900000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	6200000	USD
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3900000	USD
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	6900000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	50092300	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1068049	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	789640	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	48234611	shares
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	516757000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4614000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7719000	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	638000000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M
CY2021	us-gaap	Lease Cost LeaseCost	36983000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	161974000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11056000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	185323000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	196379000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10567000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10567000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4183000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6083000	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	10266000	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	31097000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	2406000	USD
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	3020000	USD
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	460000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	9693000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y9M18D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1098
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0558
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	10019000	USD
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	460000	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3088000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	84078000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	32075000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	4628000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	38898000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	4275000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	39346000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1674000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	38525000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	210000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	34791000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	196000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	117215000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	300850000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	10983000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	104471000	USD
CY2021Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	717000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	196379000	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	10266000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11056000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4183000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	185323000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6083000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	25490000	USD
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	1729000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	28837000	USD
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	1547000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	27633000	USD
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	1174000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	28207000	USD
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	9000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	27474000	USD
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	0	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	116155000	USD
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	253796000	USD
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	4459000	USD
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	1202000	USD
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	3257000	USD
CY2020Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	1261000	USD
CY2020Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	1996000	USD
CY2021	us-gaap	Longterm Purchase Commitment Period LongtermPurchaseCommitmentPeriod	P4Y
CY2021Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	201080000	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	201080000	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	201080000	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	201080000	USD
CY2021Q4	us-gaap	Purchase Obligation PurchaseObligation	804320000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2580324000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-719636000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-277244000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	612000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	68000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-90000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2579712000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-719568000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-277334000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	49000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-188000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	18000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	4000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	27000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-193000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	23000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	49000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-188000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	23000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	49000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-188000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.029
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.002
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.002
CY2021	lcid	Effective Income Tax Rate Reconciliation Mark To Market Adjustment Percent EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustmentPercent	-0.085
CY2020	lcid	Effective Income Tax Rate Reconciliation Mark To Market Adjustment Percent EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustmentPercent	-0.034
CY2019	lcid	Effective Income Tax Rate Reconciliation Mark To Market Adjustment Percent EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustmentPercent	-0.011
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.003
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.001
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.008
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.007
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.028
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.019
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.100
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.201
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.208
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	519410000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	265799000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	71783000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	40454000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	22559000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2554000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	20180000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	499000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	3774000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	2498000	USD
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	0	USD
CY2020Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	489000	USD
CY2021Q4	lcid	Deferred Tax Assets Tenant Improvement Allowance DeferredTaxAssetsTenantImprovementAllowance	0	USD
CY2020Q4	lcid	Deferred Tax Assets Tenant Improvement Allowance DeferredTaxAssetsTenantImprovementAllowance	8777000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	59894000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	39502000	USD
CY2021Q4	lcid	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	52592000	USD
CY2020Q4	lcid	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	0	USD
CY2021Q4	lcid	Deferred Tax Assets Right Of Use Assets DeferredTaxAssetsRightOfUseAssets	-41707000	USD
CY2020Q4	lcid	Deferred Tax Assets Right Of Use Assets DeferredTaxAssetsRightOfUseAssets	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4773000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	672898000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	360573000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	672898000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	360573000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	0	USD
CY2020Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	672900000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	360600000	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	312300000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	185800000	USD
CY2016Q4	lcid	Operating Loss Carryforwards Amount Nullified By Ownership Change OperatingLossCarryforwardsAmountNullifiedByOwnershipChange	12000000	USD
CY2016Q4	lcid	Tax Credit Carryforward Amount Nullified By Ownership Change TaxCreditCarryforwardAmountNullifiedByOwnershipChange	15000000	USD
CY2016Q4	lcid	Net Tax Credit Amount Nullified By Ownership Change NetTaxCreditAmountNullifiedByOwnershipChange	3000000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	72300000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	42900000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	20600000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	500000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2600000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2600000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	11000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	42894000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	20635000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11647000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	21000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	4000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	2000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	31336000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	22382000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	8995000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1900000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	142000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	-1000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	60000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	72330000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	42894000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	20635000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	45000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	-16000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	3000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	20000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	7000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2579761000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-719380000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-277357000	USD
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2167332000	USD
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
CY2019	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4747093000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4747093000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-705596000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-705596000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-269422000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-269422000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	740393759	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	740393759	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24825944	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24825944	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20595229	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20595229	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20595229	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20595229	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.41
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.41
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-28.42
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-28.42
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-13.08
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-13.08
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	177417887	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1029381821000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	573435179000	shares
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD

Files In Submission

Name	View Source	Status
R30.htm	Edgar Link	pending
0001628280-22-004253-index-headers.html	Edgar Link	pending
0001628280-22-004253-index.html	Edgar Link	pending
0001628280-22-004253.txt	Edgar Link	pending
0001628280-22-004253-xbrl.zip	Edgar Link	pending
exhibit46descriptionofsecu.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
fy21-ex1027dhingra_gaganxo.htm	Edgar Link	pending
fy21-ex211listofsubsidiari.htm	Edgar Link	pending
fy2110k-231auditorconsent.htm	Edgar Link	pending
fy2110k-ex311.htm	Edgar Link	pending
fy2110k-ex312.htm	Edgar Link	pending
fy2110k-ex321.htm	Edgar Link	pending
fy2110k-ex322.htm	Edgar Link	pending
image_1a.jpg	Edgar Link	pending
image_2a.jpg	Edgar Link	pending
lcid-20211231.htm	Edgar Link	pending
lcid-20211231.xsd	Edgar Link	pending
lcid-20211231_cal.xml	Edgar Link	unprocessable
lcid-20211231_def.xml	Edgar Link	unprocessable
lcid-20211231_g1.jpg	Edgar Link	pending
lcid-20211231_htm.xml	Edgar Link	completed
lcid-20211231_lab.xml	Edgar Link	unprocessable
lcid-20211231_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LCID
Lucid Group, Inc. Stock $lcid

2021 Q4 Form 10-K Financial Statement

#000162828022004253 Filed on February 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LCID Lucid Group, Inc. Stock $lcid

2021 Q4 Form 10-K Financial Statement

#000162828022004253 Filed on February 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LCID
Lucid Group, Inc. Stock $lcid